Log In
BCIQ
Print this Print this
 

RGI-3100

  Manage Alerts
Collapse Summary General Information
Company Regimmune Corp.
DescriptionLiposome encapsulating proinsulin
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today